178 results about "Treatment monitoring" patented technology

A system and a method for managing patient treatment stores in the database a patient history for each patient including data related to observations, test results, diagnoses, treatment regimen(s) and a treatment plan associated with the patient. The treatment plan is administered to the patient and medical device operating data related to the tasks of the associated treatment regimen is stored in the database. A reminder is issued if a task associated with the treatment regimen is not completed on time and the effectiveness of the treatment regimen is evaluated based upon the data stored in the database so that only effective treatment regimens are retained in the system. The system performs treatment planning, treatment monitoring, hospital monitoring, healthcare insurance billing, patient billing, research and analysis support, supply chain management and personnel scheduling.

The present invention provides for the development of endocytosis-sensitive probes, and a remote method for measuring cellular endocytosis. These probes are based on the reduced water permeability of a nanoparticle or liposomal delivery system, and inherent degradability or disruption of barrier integrity upon endocytosis. The invention also provides for liposomes having combined therapeutic and diagnostic utilities by co-encapsulating ionically coupled diagnostic and therapeutic agents, in one embodiment, by a method using anionic chelators to prepare electrochemical gradients for loading of amphipathic therapeutic bases into liposomes already encapsulating an imaging agent. The invention provides for imaging of therapeutic liposomes by inserting a lipopolymer anchored, remotely sensing reporter molecules into liposomal lipid layer. The invention allows for an integrated delivery system capable of imaging molecular fingerprints in diseased tissues, treatment, and treatment monitoring.

The invention provides a turbidimetric rapid detection kit for myocardial infarction nano-immunoenhancement. The turbidimetric rapid detection kit comprises a reaction-detection integrated device, and a detection kit arranged in the reaction device, wherein a reagent R1, a reagent R2 and a calibrator are contained in the detection kit; simultaneously, quantitative detection for five important myocardial infarction-related biomarkers in one sample can be realized, and the five important biomarkers include content of troponin-I, content of D-dimer, content of myoglobin, content of hypersensitive C-reactive protein (hs-CRP) and content of heart-type fatty acid binding protein (FABP); and the turbidimetric rapid detection kit has an important clinical significance in the aspects of early diagnosis and disease course monitoring for myocardial infarction, treatment monitoring for medicines, and the like. The turbidimetric rapid detection kit provided by the invention realizes the integration of the reagents and the reaction device, and is simple, rapid and accurate to operate, high in sensitivity, strong in specificity, and low in detection cost; and the turbidimetric rapid detection kit is a detection/reagent measurement integrated kit suitable for outpatient and emergency treatment/clinical detection, and wide in instrument application range.

This disclosure describes dialysis treatment monitoring systems and methods for operating dialysis treatment monitoring systems. The disclosure describes novel systems and methods for collecting and processing dialysis treatment information from a patient.

The invention discloses a graded diagnosis and treatment evaluating method based on data mining. The method comprises the steps: extracting essential information and diagnosis and treatment information on patients from medical records, associating the essential information and the diagnosis and treatment information with disease category information and medical institution information, and firstly, carrying out data cleaning and missing value filling so as to divide the patients into patients of different flow directions; then, calculating graded diagnosis and treatment monitoring indexes by using the data; portraying visiting behaviors and features of different patients by a GainRatioAttributeEva feature selection algorithm and a RIPPER sorting algorithm. According to the method, through evaluating graded diagnosis and treatment by qualitative indexes and quantified indexes, the defects in the current graded diagnosis and treatment evaluating methods that only the quantified indexes exist, the indexes are required to be reported layer upon layer, mis-reporting and confused reporting occur during reporting, and the tracking of reasons behind the indexes is absent are overcome; by using a data mining technology, graded diagnosis and treatment evaluation is more timely and accurate.

A heat treatment monitoring system comprises a heat treatment machine comprising a heat treatment chamber, a double glass window comprising an inside window and an outside window, and an illumination apparatus for illuminating the inside of the heat treatment chamber, and a monitoring apparatus mounted to the heat treatment machine and comprising a camera to observe the inside of the heat treatment chamber through the inside window, wherein the visible transmittance of the outside window is lower than the visible transmittance of the inside window to reduce reflections within the double glass window structure and outside illumination effects on image processing of images recorded by the camera.

The invention discloses an obstructive sleep apnea syndrome treatment monitoring system, and aims to solve the technical problem of eliminating harms brought by obstructive sleep apnea syndrome to a patient. The obstructive sleep apnea syndrome treatment monitoring system is provided with a collector, and a health care treatment mattress system used for sending collected patient information to a remote monitoring analysis center and receiving instructions of the remote monitoring analysis center, wherein the health care treatment mattress system is provided with a mattress; and inflatable air bags are arranged on the mattress. Compared with the prior art, the obstructive sleep apnea syndrome treatment monitoring system has the advantage that when a severe/moderate obstructive sleep apnea syndrome patient sleeps, the positions and the heights of the air bags in the mattress are remotely controlled and adjusted according to the prompt of an analysis signal of abnormal blood oxygenation content, so as to help the patient to adjust the sleep posture, open a respiratory tract and comprehensively improve the obstructive sleep apnea syndrome hypoxia phenomenon occurring to the patient in the sleep process; and the obstructive sleep apnea syndrome treatment monitoring system has the characteristics that paralysis is prevented, the sleep quality of the patient is improved, the falling-preventing air bags are provided, and sleep safety of the patient is guaranteed.

The invention relates to a difunctional tumor diagnosis reagent and a method thereof, and belongs to the nano-technological field, the biological bionic field, and the immunology and biomedicine crossing field. The invention especially provides the difunctional tumor diagnosis reagent which is composed of a protein shell for specifically identifying cancer tissues and/or cancer cells and an inorganic nanometer core having a peroxidase catalytic activity. The invention also provides a kit comprising the reagent, and a method for detecting tumors in an individual through using the reagent. The difunctional tumor diagnosis reagent and the method can be used for cancer screening, early-stage diagnosis, treatment monitoring, cancer cell metastasis analysis, postoperative recurrence evaluation or basic cancer researches. The difunctional tumor diagnosis reagent integrates two functions comprising tumor specific identification and coloration into one, and enables the tumor specific identification and the coloration to be completely in a one step manner without the marking of a secondary antibody, a tertiary antibody or HRP or a signal molecule, and the operation is simple and convenient.

The invention discloses new applications of an antibody of GDF15 (Growth differentiation factor 15) protein. The invention provides the following three applications of the antibody of the GDF15 protein: 1. the application in preparing a reagent for assisting to identify a hepatitis C patient or a hepatitis B patient; 2. the application in preparing a reagent kit for assisting to identify the hepatitis C patient or the hepatitis B patient; and 3. the application in preparing a reagent kit for assisting to identify the hepatitis C progress of the hepatitis C patient, wherein the hepatitis C progress is chronic hepatitis C, hepatitis C cirrhosis or liver cancer. On the basis of the three applications, the antibody of the GDF15 protein can be prepared into three reagent kits. The reagent kit can be used for the serological diagnosis of viral hepatitis (the hepatitis C or the hepatitis B) and judging the disease progress (the chronic hepatitis C, the hepatitis C cirrhosis or the liver cancer) and for prognosis and viral hepatitis treatment monitoring and has great value for the diagnosis and the treatment of the hepatitis C and the hepatitis B.

A tool for monitoring a course of treatment for a patient, including standards of care making up the course of treatment. The tool permits tracking of multiple patients, their diagnoses, corresponding treatment regimens, and status of those regimens. Once a diagnosis is selected by a physician, the embodiment may list the various steps and/or actions undertaken in a recommended course of treatment for that diagnosis. Such steps/actions can include tests to be performed on the patient, drugs or prescriptions to be prescribed to the patient, physical activity to be undertaken by the patient, assessments to be made by a practitioner, environmental factors to be applied to the patient and so forth. The tool also lists particular standards of care for a given diagnosis, as well as which standards of care are incomplete. The tool may also present a patient's location.

The present invention is related to the use of 5-hydroxymethylcytosine or a biomolecule having general structure of 5-hydroxymethycytosine as a biomarker for the detection, treatment monitoring, and prognostic prediction of cancer.

Exemplary embodiments of an apparatus and a method can be provided. For example, a first information can be obtained for at least one signal that is (i) at least partially periodic and (ii) associated with at least one structure. In addition, a second information associated with the structure can be generated at multiple time points within a single cycle of the at least one signal. The second information can include information for the structure below a surface thereof. Further, it is possible to generate a third information based on the first information and the second information, where the third information is associated with at least one characteristic of the structure.

The invention discloses a system for monitoring treatment of ischemic cerebrovascular disorder on the basis of image information. The system comprises: a clinical image processing module, a before-treatment and after-treatment image analysis module, and a treatment monitoring module. The clinical image processing module is used for performing importing, saving, format converting, grouping and image normalizing to clinic cerebral blood flow perfusion images, and generating cerebral blood flow perfusion templates; the before-treatment and after-treatment image analysis module is used for performing contrastive analysis to cerebral blood flow perfusion sequential images before clinical treatment and after clinical treatment, computing and obtaining quantitative parameters for therapeutic effect evaluation; the treatment monitoring module is used for selecting the quantitative parameters, establishing the relation between the quantitative parameters and traditional clinic assessment of recovery level, generating a specialist judging module of therapeutic effect evaluation, and monitoring the treatment process for ischemic cerebrovascular disorder on the basis of the specialist judging module.

The invention discloses a radioactive ray monitoring and treating system. The radioactive ray monitoring and treating system comprises a location monitoring device, a movement monitoring device, a treating monitoring device, a data processing device and an accelerator control device. The location monitoring device is used for obtaining location data of a patient by monitoring a magnetic field of a body surface location corresponding to an area where tumors of the patient are located; the movement monitoring device is used for obtaining location data of a target area and an organ at risk by monitoring a magnetic filed of an in-vivo location corresponding to an area where the tumors and/or the organic at risk of the patient is located; the treating monitoring device is used for obtaining blade location data by monitoring a magnetic field of blade locations of a multi-blade collimator of an accelerator; the data processing device is used for judging whether the patient location data, the location data of the target area and the organ at risk and the blade location data all met preset location requirements or not and sending out an instruction used for controlling the accelerator control device to start or stop irradiation according to a judgment result; the accelerator control device is used for starting or stopping radiation treatment according to the instruction sent out by the data processing device. According to the radioactive ray monitoring and treating system, a magnetic localization mode is adopted, and the accuracy of radiation treatment is improved.

Embodiments provide cloud-based ophthalmic eyelid treatment monitoring systems and cloud-based methods for monitoring ophthalmic eyelid treatment. The monitoring system includes a moldable warming device, a monitor, and a cloud server. The moldable warming device includes a heating disc, a resonance frequency stimulation vibration generator (RFSVG), a coupling device, a mask, and a sensor array. The mask is configured to hold the heating disc, the RFSVG, and the coupling device for use in parallel utility. The sensor array is configured to generate a data stream responsive to a vibration and heating profile of a user's individual patient eyelid and periorbital three-dimensional anatomy and surface topography. The monitor is configured to receive the data stream from the sensor array and configured to transmit the data stream to the cloud server. The cloud server is configured to process the data stream so as to determine tuning parameters of the vibration and heating profile of the user's individual patient eyelid and periorbital three-dimensional anatomy and surface topography, and configured to transmit the tuning parameters to the monitor. The monitor is configured to receive the tuning parameters from the cloud server, configured to display information related to the tuning parameters, and configured to transmit the tuning parameters to the moldable warming device. The moldable warming device is configured to receive the tuning parameters from the monitor and configured to generate thermal and vibratory energy according to the tuning parameters.

The present invention describes a method for the in vitro diagnosis, prognosis and/or treatment monitoring of neurodegenerative, neurological and inflammation-based diseases, wherein the method comprises the steps: a) isolating microglial microvesicles (MVs) from biological fluids obtained from an individual; b) collecting the microRNA (miRNA) contained into said MVs; c) determining the expression profile of a predetermined set of miRNA; d) comparing said expression profile to one or several reference expression profiles, wherein the comparison of said determined expression profile to said one or several reference expression profiles allows for the diagnosis, prognosis and/or treatment monitoring of the disease.

The invention belongs to the technical field of biomedical inspection, and particularly relates to an enzyme-linked immunosorbent assay kit for detecting the content of Myofibrillogenesis Regulator-1S (MR-1S). The enzyme-linked immunosorbent assay kit consists of the following reagents: an anti-human MR-1S antibody-precoated microplate or MR-1S antigen-precoated microplate; a bottle of anti-human MR-1S antibody enzyme-marked solution; MR-1S standard solutions of serial concentrations; a bottle of positive quality control solution; a bottle of negative quality control solution; a bottle of normal saline; cleaning mixture; sample diluent; blocking solution; substrate solution; and stop solution. Compared with the prior art, the invention has the advantages that: the detected result of the established kit shows that the kit can quantitatively detect the concentration of MR-1S, and the detected result can reflect the change range and the development trend of human MR-1S and meets the requirements of clinical diagnosis and treatment monitoring, moreover, an assay can be fulfilled in 120 minutes, the reagents and the method are stable, and are easy to operate, the sensitivity is high, the specificity is stronger, and the kit has a better clinical application prospect.

The invention discloses a stony desertification treatment effect multi-index monitoring and evaluating method based on multi-source remote sensing data. The method comprises the following steps: (1) acquiring high-medium-low multi-source remote sensing data before and after stony desertification treatment in a monitoring area according to actual requirements; (2) calculating the vegetation coverage FVC and the leaf area index LAI of different time phases of the stony desertification control area according to the remote sensing data obtained in the step (1); (3) carrying out binarization processing according to the change conditions of the vegetation coverage FVC and the leaf area index LAI obtained in the step (2); (4) obtaining a comprehensive change condition FL of the vegetation coverage and the leaf area index; and (5) constructing a stony desertification treatment effect evaluation system. According to the invention, the defect of monitoring the physiological state of the vegetation in the treatment area in the current rocky desertification treatment monitoring is overcome, and the beneficial effect of monitoring the treatment situation more systematically and comprehensivelyis achieved.

The invention discloses a tooth orthodontic treatment monitoring method based on an intraoral image and a three-dimensional model. The tooth orthodontic treatment monitoring method comprises the following steps that step 1, a preprocessed intraoral image and a dental jaw three-dimensional digital model of a patient at a P1 stage are obtained; step 2, tooth-gingiva and tooth-tooth segmentation is performed on the dental jaw three-dimensional digital model based on the intraoral image of the patient in the P1 stage, a segmented dental jaw three-dimensional digital model is obtained; step 3, a preprocessed intraoral image of the patient in a P2 stage is obtained; and step 4, the segmented dental jaw three-dimensional digital model is converted according to the intraoral image of the patient in the P2 stage, and a dental jaw three-dimensional digital model of the P2 stage and coordinate transformation data and morphological change data of the dental jaw models from the P1 stage to the P2 stage are generated. According to the tooth orthodontic treatment monitoring method based on the intraoral image and the three-dimensional model, coordinate transformation and form change conditions ofteeth of the patient after tooth orthodontic treatment can be known only by shooting the intraoral image, so that a scanner is prevented from being used for scanning an oral cavity after treatment.